Immunomodulatory Potential of Curcuma longa Extract as Adjuvant Therapy for Peritonitis: A Systematic Review of Inflammatory Biomarkers IL-6 and Myeloperoxidase
Downloads
Peritonitis is a severe inflammatory condition of the peritoneum associated with high morbidity and mortality, often progressing to sepsis due to excessive inflammatory responses. Pro-inflammatory cytokines such as interleukin-6 (IL-6) and neutrophil-derived enzymes like myeloperoxidase (MPO) play critical roles in disease progression and tissue damage. Current treatments primarily focus on infection control; however, adjunctive therapies targeting inflammation remain limited. This study aims to evaluate the potential of Curcuma longa extract as an adjuvant therapy in modulating IL-6 levels and MPO activity in peritonitis. This research employed a systematic review design following PRISMA 2020 guidelines. Literature was collected from Scopus, PubMed, Google Scholar, and ScienceDirect using predefined inclusion and exclusion criteria. A total of four eligible experimental studies (in vivo and in vitro) were analyzed. The findings demonstrate that Curcuma longa extract, particularly curcumin, significantly reduces IL-6 expression and modulates MPO activity, indicating decreased inflammatory response and neutrophil infiltration. These effects are associated with the inhibition of key inflammatory pathways such as NF-κB and MAPK.In conclusion, Curcuma longa shows promising potential as an adjunctive therapy for peritonitis by attenuating inflammatory biomarkers. However, further standardized studies and clinical trials are required to confirm its efficacy and optimal therapeutic dosage.
Abu-Hijleh, H. M., et al. (2024). The therapeutic role of curcumin in inflammation and post-surgical outcomes. Food Reviews International, 40(1), 293–308. https://doi.org/10.1080/87559129.2023.2166525
Akçakaya, A., & Akçakaya, A. (2023). Peritonitis: An overview. Bezmialem Science, 11(3), 242–246. https://doi.org/10.14235/BAS.GALENOS.94695
Aufricht, C., et al. (2012). Peritoneal infection and inflammation. Mediators of Inflammation, 2012, 456985. https://doi.org/10.1155/2012/456985
Aurelia, N., et al. (2022). Effect of curcumin on interleukin-6 expression and malondialdehyde levels in liver fibrosis. Open Access Macedonian Journal of Medical Sciences, 10(B), 2319–2326
Bezzerri, V., et al. (2025). A focus on inflammatory and bacterial biomarkers in secondary peritonitis. Cells, 14(21), 1653. https://doi.org/10.3390/cells14211653
Clements, T. W., Tolonen, M., Ball, C. G., & Kirkpatrick, A. W. (2021). Secondary peritonitis and intra-abdominal sepsis: An increasingly global disease in search of better systemic therapies. Scandinavian Journal of Surgery, 110(2), 139–149. https://doi.org/10.1177/1457496920984078
D, S., et al. (2015). Effect of curcumin in experimental peritonitis. The Indian Journal of Surgery, 77(6), 502. https://doi.org/10.1007/s12262-015-1303-y
Dehzad, M. J., Ghalandari, H., Nouri, M., & Askarpour, M. (2023). Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Cytokine, 164, 156144. https://doi.org/10.1016/j.cyto.2023.156144
de Oliveira, M. R. (2024). Enhancing the bioavailability and bioactivity of curcumin for disease prevention and treatment. Nutrients, 16(7), 961. https://doi.org/10.3390/nu16070961
Ghandadi, M., & Sahebkar, A. (2017). Curcumin: An effective inhibitor of interleukin-6. Current Pharmaceutical Design, 23(6), 921–931. https://doi.org/10.2174/1381612822666161006151605
Gorabi, A. M., et al. (2021). Effect of curcumin on proinflammatory cytokines: A meta-analysis of randomized controlled trials. Cytokine, 143, 155541. https://doi.org/10.1016/j.cyto.2021.155541
Kaboutari, J., et al. (2024). Effects of the slow-release curcumin-loaded selenium nanoparticles on experimental peritonitis. Iranian Journal of Veterinary Medicine, 18(4), 555–566. https://doi.org/10.32598/ijvm.18.4.1005414
Kavyani, Z., et al. (2022). Efficacy of curcumin supplementation on inflammatory biomarkers: An umbrella meta-analysis of randomized controlled trials. International Immunopharmacology, 111, 109066. https://doi.org/10.1016/j.intimp.2022.109066
Khan, A. A., Alsahli, M. A., & Rahmani, A. H. (2018). Myeloperoxidase as an active disease biomarker: Recent biochemical and pathological perspectives. Medical Sciences, 6(2), 33. https://doi.org/10.3390/medsci6020033
Lahori, D., & Ramana, K. V. (2025). Curcumin in inflammatory complications: Therapeutic applications and clinical evidence. International Journal of Molecular Sciences, 26(19), 9366. https://doi.org/10.3390/ijms26199366
Lin, W., Chen, H., Chen, X., & Guo, C. (2024). The roles of neutrophil-derived myeloperoxidase (MPO) in diseases: The new progress. Antioxidants, 13(1), 132. https://doi.org/10.3390/antiox13010132
Liu, M., et al. (2025). Regulation mechanism of curcumin mediated inflammatory pathway and its clinical application: A review. Frontiers in Pharmacology, 16, 1642248. https://doi.org/10.3389/fphar.2025.1642248
Liu, S., et al. (2016). The protective role of curcumin in zymosan-induced multiple organ dysfunction syndrome in mice. Shock, 45(2), 209. https://doi.org/10.1097/SHK.0000000000000502
Liu, T., Zhang, L., Joo, D., & Sun, S. C. (2017). NF-κB signaling in inflammation. Signal Transduction and Targeted Therapy, 2, 17023. https://doi.org/10.1038/sigtrans.2017.23
Liu, Y., & Chen, L. (2024). Impact of interleukin-6 levels on acute lung injury risk and disease severity in critically ill sepsis patients. World Journal of Clinical Cases, 12(23), 5374–5381. https://doi.org/10.12998/wjcc.v12.i23.5374
Mihajlovic, D., et al. (2016). Secondary peritonitis—Evaluation of 204 cases and literature review. European Review for Medical and Pharmacological Sciences, 20(3), 479–487
Musazadeh, V., et al. (2024). The effects of curcumin supplementation on biomarkers of inflammation, oxidative stress, and endothelial function: A meta-analysis of meta-analyses. Journal of Functional Foods, 119, 106369. https://doi.org/10.1016/j.jff.2024.106369
Ndrepepa, G. (2019). Myeloperoxidase – A bridge linking inflammation and oxidative stress with cardiovascular disease. Clinica Chimica Acta, 493, 36–51. https://doi.org/10.1016/j.cca.2019.02.022
Ng, S. W., et al. (2020). In vitro evaluation of curcumin-encapsulated chitosan nanoparticles against feline infectious peritonitis virus and pharmacokinetics study in cats. BioMed Research International, 2020, 3012198. https://doi.org/10.1155/2020/3012198
Panahi, Y., et al. (2015). Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome. Clinical Nutrition, 34(6), 1101–1108. https://doi.org/10.1016/j.clnu.2014.12.019
Pour, A. H. M., et al. (2019). Curcumin effects on inflammatory biomarkers in patients with unstable angina. Avicenna Journal of Phytomedicine, 9(5), 428
Saber, A., Venkataramaiah, K. A., & Fathollahi, M. (2023). Nano formulation approaches for curcumin delivery: A review. Journal of Drug Delivery Science and Technology, 80, 104181. https://doi.org/10.1016/j.jddst.2023.104181
Tanvir, E. M., et al. (2017). Antioxidant properties of turmeric (Curcuma longa) varieties. Journal of Food Quality, 2017, 8471785. https://doi.org/10.1155/2017/8471785
Vollono, L., et al. (2019). Potential of curcumin in skin disorders. Nutrients, 11(9), 2169. https://doi.org/10.3390/nu11092169
Yin, H., et al. (2024). NF-κB in biology and targeted therapy: New insights. Signal Transduction and Targeted Therapy, 9(1), 53. https://doi.org/10.1038/s41392-024-01757-9
Zhao, J., et al. (2024). Improving curcumin bioavailability. Food Research International, 190, 114619. https://doi.org/10.1016/j.foodres.2024.114619
Copyright (c) 2026 Ishak Andreas Soritua Lumban Gaol, Endang Mahati, Erik Prabowo
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
